Filing Details

Accession Number:
0001209191-19-047610
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-28 16:30:16
Reporting Period:
2019-08-26
Accepted Time:
2019-08-28 16:30:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1347178 Vanda Pharmaceuticals Inc. VNDA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1263499 W Richard Dugan 298 Beacon Circle
Boalsburg PA 16827
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-08-26 15,000 $14.78 50,770 No 4 M Direct
Common Stock Disposition 2019-08-26 15,000 $14.85 35,770 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Nonstatutory Stock Option (Right to Buy) Disposition 2019-08-26 15,000 $0.00 15,000 $14.78
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-08-26 No 4 M Direct
Footnotes
  1. Represents shares of common stock sold to cover the payment of the option exercise price (which represents 99.94% of the proceeds from the sales made by the Reporting Person) of the option, which was set to expire on August 26, 2019.
  2. The option vested in 12 equal monthly installments beginning on September 27, 2009.